Retatrutide is a next-generation, triple-receptor incretin peptide that acts on the GLP-1, GIP and glucagon pathways at once one of the most-studied compounds in the current wave of metabolic research
In women, excess body weight is associated with ovulatory dysfunction, polycystic ovary syndrome (PCOS), irregular menstrual cycles, and reduced conception rates
Adequate nutrition during this period is not about weight loss optimization
The card is effective for up to 12 refills of 28-day prescriptions
Other side effects include gastrointestinal adverse effects, dehydration-related acute kidney injury, worsening diabetic retinopathy in some patients, aspiration risk during general anesthesia and gallbladder disease [5, 9, 15]
doi: 10.1002/ajmg.c.30087